Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways: Erratum

por Zhang, Jinjun, Du, Yaying, Zhang, Xiaoxue, Li, Mengchen, Li, Xingrui
Publicado 2023

Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer

por Liu, Yun, Du, Yaying, Hu, Xiaopeng, Zhao, Lu, Xia, Wenfei
Publicado 2018

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways

por Zhang, Jinjun, Du, Yaying, Zhang, Xiaoxue, Li, Mengchen, Li, Xingrui
Publicado 2018

Long non-coding RNA BLACAT1 promotes breast cancer cell proliferation and metastasis by miR-150-5p/CCR2

por Hu, Xiaopeng, Liu, Yun, Du, Yaying, Cheng, Teng, Xia, Wenfei
Publicado 2019

LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15

por Liu, Yun, Cheng, Teng, Du, Yaying, Hu, Xiaopeng, Xia, Wenfei
Publicado 2020

MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36

por Xia, Wenfei, Liu, Yun, Du, Yaying, Cheng, Teng, Hu, Xiaopeng, Li, Xingrui
Publicado 2020

One-step generation of modular CAR-T with AAV-Cpf1

por Dai, Xiaoyun, Park, Jonathan J., Du, Yaying, Kim, Hyunu R., Wang, Guangchuan, Errami, Youssef, Chen, Sidi
Publicado 2019

Current landscape of personalized clinical treatments for triple-negative breast cancer

por Zhang, Jun, Xia, Yu, Zhou, Xiaomei, Yu, Honghao, Tan, Yufang, Du, Yaying, Zhang, Qi, Wu, Yiping
Publicado 2022

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer

por Xu, Tao, Wang, Zhen, Liu, Jiahao, Wang, Ge, Zhou, Dongchen, Du, Yaying, Li, Xingrui, Xia, Yu, Gao, Qinglei
Publicado 2022

Mutational profiling of Chinese patients with thyroid cancer

por Du, Yaying, Zhang, Shu, Zhang, Gang, Hu, Jiaying, Zhao, Lianhua, Xiong, Yuanyuan, Shen, Lu, Chen, Rongrong, Ye, Ke, Xu, Yan
Publicado 2023

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

por Chen, Li, Qi, Yihang, Kong, Xiangyi, Su, Zhaohui, Wang, Zhongzhao, Wang, Xiangyu, Du, Yaying, Fang, Yi, Li, Xingrui, Wang, Jing
Publicado 2022

SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1

por Kong, Deguang, Li, Anping, Liu, Yu, Cui, Qiuxia, Wang, Kun, Zhang, Dan, Tang, Jianing, Du, Yaying, Liu, Zhisu, Wu, Gaosong, Wu, Kongming
Publicado 2019

Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery

por Yang, Xue, Wu, Yonglin, Xu, Shaojie, Li, Hanning, Peng, Chengcheng, Cui, Xiaoqing, Dhoomun, Deenraj Kush, Wang, Ge, Xu, Tao, Dong, Menglu, Li, Xingrui, Du, Yaying
Publicado 2023

In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma

por Ye, Lupeng, Park, Jonathan J., Dong, Matthew B., Yang, Quanjun, Chow, Ryan D., Peng, Lei, Du, Yaying, Guo, Jianjian, Dai, Xiaoyun, Wang, Guangchuan, Errami, Youssef, Chen, Sidi
Publicado 2019